Ventyx Biosciences, Inc. (VTYX) - Quarterly Income Statement

Home
VTYX
Financials

1.2 (USD) • At close April 25, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	1.076	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.316	0.408	0.403	0.265	0.139	0.134	0.15	0.127	0.103	0.09	0.016	0.009	0.004	0.001	0	0	0	0
Gross Profit Numbers are in millions	0	0	-0.316	-0.408	0.673	-0.265	-0.139	-0.134	-0.15	-0.127	-0.103	-0.09	-0.016	-0.009	-0.004	-0.001	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.625	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	24.821	30.629	27.805	33.747	40.32	49.75	48.56	35.437	30.185	25.468	14.676	17.409	13.824	10.545	9.511	24.601	1.307	1.99	1.535	1.535
General & Administrative Expenses Numbers are in millions	7.597	7.923	7.907	8.021	8.326	8.201	8.585	7.115	8.386	5.952	5.722	5.338	4.002	2.242	1.675	0.747	0.133	0.245	0.153	0.153
Selling & Marketing Expenses Numbers are in millions	0	0	-0.316	-0.408	-0.903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	7.597	7.923	7.591	7.613	7.423	8.201	8.585	7.115	8.386	5.952	5.722	5.338	4.002	2.242	1.675	0.747	0.133	0.245	0.153	0.153
Other Expenses Numbers are in millions	0	0	-0.021	-0.031	-0.028	-0.008	-0.005	-0.001	0.172	0.958	0.038	0.015	0.058	0.013	-4.373	-1.147	0	-0.001	0	0
Operating Expenses Numbers are in millions	32.418	38.552	35.396	41.36	47.743	57.951	57.145	42.552	38.571	31.42	20.398	22.747	17.826	12.787	11.186	25.348	1.44	2.235	2.103	2.103
Operating Income Numbers are in millions	-32.418	-38.552	-35.712	-41.768	-48.146	-57.951	-57.145	-42.552	-38.571	-31.42	-20.398	-22.747	-17.826	-12.787	-11.186	-25.348	-1.44	-2.235	-1.687	-1.687
Operating Income Ratio Numbers are in millions	0	0	0	0	-44.745	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.067	3.303	3.762	3.196	3.593	3.924	3.894	3.621	3.357	0.958	0.38	0.015	0.058	0.013	-4.373	-12.297	-15.262	-4.92	-0.471	-0.471
Income Before Tax Numbers are in millions	-29.351	-35.249	-31.95	-38.572	-46.753	-54.027	-53.251	-38.931	-35.214	-30.462	-20.018	-22.732	-17.768	-12.774	-15.559	-37.645	-16.702	-7.155	-2.158	-2.158
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-43.451	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0.365	7.785	-0.265	-3.899	-3.621	-0.15	-0.958	-0.342	-0.015	0.058	0.013	-4.373	-1.048	-1.287	0.094	-0.471	-0.471
Net Income Numbers are in millions	-29.351	-35.249	-31.95	-38.572	-46.753	-54.027	-53.251	-35.31	-35.064	-29.504	-20.018	-22.717	-17.768	-12.774	-15.559	-37.645	-16.702	-7.155	-2.158	-2.158
Net Income Ratio Numbers are in millions	0	0	0	0	-43.451	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.43	-0.5	-0.45	-0.62	-0.79	-0.92	-0.91	-0.61	-0.62	-0.57	-0.39	-0.45	-0.38	-0.27	-0.74	-1.78	-0.79	-0.34	-1.1	-1.1
EPS Diluted Numbers are in millions	-0.43	-0.5	-0.45	-0.62	-0.79	-0.92	-0.91	-0.61	-0.62	-0.57	-0.39	-0.45	-0.38	-0.27	-0.74	-1.78	-0.79	-0.34	-1.1	-1.1
EBITDA Numbers are in millions	-32.103	-38.243	-35.396	-41.36	-49.943	-57.686	-57.006	-42.418	-35.064	-31.293	-20.295	-22.657	-17.752	-12.765	-15.555	-37.545	-1.44	-7.061	0	0
EBITDA Ratio Numbers are in millions	0	0	0	0	-46.415	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Ventyx Biosciences, Inc.

NASDAQ:VTYX Add to watchlist

NASDAQ:VTYX